Jon S. Saxe, Director at PDL BIOPHARMA, INC. (PDLI), sold 10,000 shares at $32.04 ($317K) on 2006-03-13, disclosed to the SEC on 2006-03-15.
Scheduled sale ($317k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.40 | 5,000 | $157K | 49.5% |
| 2 | $32.04 | 5,000 | $160K | 50.5% |
| Total | $31.72 avg | 10,000 | $317K | 100% |
| Filing → |
| DRRX | BUY | 2019-05-28 | $19K | — | Filing → |
| DRRX | BUY | 2019-05-15 | $7K | — | Filing → |
| DRRX | BUY | 2019-05-14 | $55K | — | Filing → |